Rivaroxaban CAS 366789-02-8 Bohloeki >99.5% (HPLC) Factory API High Quality

Tlhaloso e Khutšoanyane:

Lebitso la lik'hemik'hale: Rivaroxaban

CAS: 366789-02-8

Bohloeki: >99.5% (HPLC)

Ponahalo: Phofo e tšoeu kapa e batlang e le tšoeu

API Boleng bo Phahameng, Tlhahiso ea Khoebo

E-Mail: alvin@ruifuchem.com


Lintlha tsa Sehlahisoa

Lihlahisoa tse Amanang

Li-tag tsa Sehlahisoa

Tlhaloso:

Lintho tsa Lik'hemik'hale:

Lebitso la Lik'hemik'hale Rivaroxaban
Litlhaloso tse tšoanang (S)-Rivaroxaban;(S) -5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;BAY 59-7939
Nomoro ea CAS 366789-02-8
Boemo ba Setoko Ka Setokong, Sekhahla sa Tlhahiso Ho fihlela ho Lithane
Foromo ea limolek'hule C19H18ClN3O5S
Boima ba Molek'hule 435.88
Brand Ruifu Chemical

Litlhaloso:

Ntho Litlhaloso
Ponahalo Phofo e Tshweu kapa e Batlileng e Tshweu
Boitsebiso A Ho kenngoa ha infrared ha Rivaroxaban ho lumellana le litekanyetso tsa litšupiso
Boitsebiso B Nako ea ho boloka tlhōrō ea tlhōrō e kholo ea tharollo ea sampole e lumellana le ea tharollo ea ts'ebetso ea ts'ebetso, joalo ka ha e fumanoa ka ho hloeka ha enantiomeric.
Enantiomeric Bohloeki RVX RC01: ≤0.15%
Mongobo (KF) ≤0.50%
Molora oa Sulfate ≤0.10%
Litšepe tse boima ≤20ppm
Acetic Acid ≤5000ppm
Lintho tse Amanang (HPLC)
RVX RC02 ≤0.15%
RVX RC03 ≤0.15%
RVX RC04 ≤0.15%
RVX RC05 ≤0.15%
RVX RC06 ≤0.15%
RVX RC07 ≤0.15%
RVX RC08 ≤0.15%
Tšilafalo Efe E 'ngoe ea Motho ka Mong ≤0.10%
Litšila ka Kakaretso <0.50%
Residual Solvents (GC)
Ethanol ≤5000ppm
Toluene ≤890ppm
Triethylamine ≤320ppm
Mokhoa oa Bohloeki / Analysis >99.5% (HPLC) (ka lebaka la anhydrous basis)
Tekanyetso ea Teko Maemo a Khoebo
Tšebeliso API;Lithethefatsi tsa antithrombotic;FXa Inhibitor

Sephutheloana le Bobolokelo:

Sephutheloana: Botlolo, Aluminium foil bag, 25kg/Cardboard Drum, kapa ho ea ka tlhokahalo ea moreki.

Boemo ba polokelo:Boloka ka lijaneng tse koetsoeng sebakeng se phodileng le se omileng;Sireletsa leseli le mongobo.

Melemo:

1

LBH:

Kopo:

Rivaroxaban(CAS:366789-02-8) (Xarelto, Bayer) ke anticoagulant ea molomo.Ke ntho e sebetsang ka molomo e tobileng Xa inhibitor.Rivaroxaban e bontšoa bakeng sa 'phekolo ea thrombosis ea methapo e tebileng le embolism ea pulmonary, le thibelo ea ho ipheta-pheta ha methapo e tebileng ea methapo le embolism ea pulmonary ho batho ba baholo'.Bakeng sa kalafo ea pele ea acute pulmonary embolism, tekanyetso e khothaletsoang ea rivaroxaban ke 15 mg habeli ka letsatsi bakeng sa matsatsi a pele a 21 e lateloa ke 20 mg hang ka letsatsi bakeng sa kalafo e tsoelang pele le ho thibela thromboembolism ea venous khafetsa.Non-Valvular Atrial Fibrillation (NVAF) ho thibela lefu la stroke & systemic embolism.Kalafo e matla ea VTE le thibelo ea VTE e iphetang [bakeng sa thrombosis e tebileng ea methapo (DVT) le pulmonary embolism (PE)].Thibelo ea liketsahalo tsa venous thromboembolic (VTE) ho opereishene e ikhethileng ea letheka kapa lengole (THR, TKR).

Ngola molaetsa wa hao mona mme o re romele wona